Recommended

Teva close to API business sale
Streamlined rAAV purification enables efficient upstream analytics – access now
First new IPF treatment in US for a decade
Webinar: Radiopharmaceuticals’ time-to-result challenge
AstraZeneca/Daiichi cancer drug boost
Takeda to move away from cell therapy
GSK appoints new CEO
news

Packaging initiative to protect COVID-19 medicines against counterfeiting launched

3
SHARES

The AlpVision COVID-19 Initiative will provide pharma companies with access to use a crytoglyph on their medicine packaging for free.

COVID-19 medicine packaging

AlpVision has announced it is launching the “AlpVision COVID-19 Initiative”, a programme aimed to help pharmaceutical companies protect their medicines relevant to COVID-19 against counterfeiting. The initiative involves using a crytoglyph on the packaging of the medicinal products.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

According to the company, COVID-19 has caused not only the pandemic, but has also created unprecedented economic challenges. In response, AlpVision has launched its initiative to support pharmaceutical companies by providing them with the necessary tools to protect COVID-19 relevant medicines and vaccines against counterfeiting for free. 

To do so, AlpVision will provide pharma companies and their suppliers with all necessary tools to deploy a cryptoglyph on their packaging. The AlpVision Cryptoglyph is a digital security feature which can be implemented and deployed within just a few weeks. The company says it is invisible to the human eye and authentication of a product protected with a cryptoglyph can be completed using a regular smartphone. The company says that the smartphone applications connect to AlpVision’s Brand Monitoring System (BMS), a centralised server platform through which pharmaceutical companies are able to monitor in real-time product authentication activities and gain important insight into counterfeiting activities.

Anti-counterfeit packaging

Authentication using smartphones [credit: AlpVision].

Furthermore, securing of packaging with a cryptoglyph is very easy as it neither changes the standard production process, nor requires additional consumables.

The AlpVision COVID-19 Initiative will start today, on 13 November 2020, and subscription will run for an initial period of three months. Participating companies will be able to protect their COVID-19 relevant products with no additional cost for the authentication feature. AlpVision says that it will provide this service gratuitously until the pandemic is officially declared as ended by the World Health Organization (WHO). 

Sterile medical packaging: the need of the hour amid the COVID-19 pandemic…

Related topics

, , ,

Related organisations

Related diseases & conditions

Share via
Share via